The relationship between inflammation and symptoms in asthma;Relation entre inflammation et symptômes dans l'asthme

Revue des Maladies Respiratoires

Volumn 25, Issue 8, 2008, Pages 933-951

  Montani, D ^a,j   Tillie Leblond, I ^b   Crestani, B ^c   De Blic, J ^d   Humbert, M ^a   Tunon de Lara, M ^e   Magnan, A ^f   Roche, N ^g   Gati, S ^h   Chanez, P ⁱ  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c BICHAT HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f L INSTITUT DU THORAX   (France)

^g HÔTEL DIEU   (France)

^h ASTRAZENECA   (United Kingdom)

ⁱ HÔPITAL SAINTE MARGUERITE   (France)

^j HÔPITAL ANTOINE BÉCLÈRE   (France)

more..

Author keywords

Asthma; Exacerbation; Inflammation; Inhaled corticosteroids; Perception; Symptoms

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; NITRIC OXIDE; THEOPHYLLINE;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CLINICAL EVALUATION; CLINICAL PRACTICE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DYSPNEA; EOSINOPHILIA; EXHALATION; FOLLOW UP; HUMAN; INFLAMMATION; INFLAMMATORY CELL; INHALATION; LUNG RECEPTOR; PARAMETER; PATHOPHYSIOLOGY; PERCEPTION; REVIEW; SPUTUM; SYMPTOM;

EID: 56249094546     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(08)74411-5     Document Type: Review

References (140)

1. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2007. http://www.ginasthma.com/Guidelineitem.asp?l1=2&l2= 1&intId=60.
2. Green RH, Brightling CE, McKenna S, Hargadon B, Neale N, Parker D, Ruse C, Hall IP, Pavord ID : Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness. Eur Respir J 2006 ; 27 : 1144-51.
3. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R : The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000 ; 161 : 9-16.
4. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID : Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002 ; 360 : 1715-21.
5. Bacci E, Cianchetti S, Bartoli M, Dente FL, Di Franco A, Vagaggini B, Paggiaro P : Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients. Chest 2006 ; 129 : 565-72.
6. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH : "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med 2004 ; 170 : 601-5.
7. Rytila P, Metso T, Heikkinen K, Saarelainen P, Helenius IJ, Haahtela T : Airway inflammation in patients with symptoms suggesting asthma but with normal lung function. Eur Respir J 2000 ; 16 : 824-30.
8. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J : Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 1997 ; 10 : 646-51.
9. Duncan CJ, Lawrie A, Blaylock MG, Douglas JG, Walsh GM : Reduced eosinophil apoptosis in induced sputum correlates with asthma severity. Eur Respir J 2003 ; 22 : 484-90.
10. Giannini D, Di Franco A, Cianchetti S, Bacci E, Dente FL, Vagaggini B, Paggiaro PL : Analysis of induced sputum before and after withdrawal of treatment with inhaled corticosteroids in asthmatic patients. Clin Exp Allergy 2000 ; 30 : 1777-84.
11. Romagnoli M, Vachier I, Tarodo de la Fuente P, Meziane H, Chavis C, Bousquet J, Godard P, Chanez P : Eosinophilic inflammation in sputum of poorly controlled asthmatics. Eur Respir J 2002 ; 20 : 1370-7.
12. Lemiere C, Ernst P, Olivenstein R, Yamauchi Y, Govindaraju K, Ludwig MS, Martin JG, Hamid Q : Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol 2006 ; 118 : 1033-9.
13. Lemiere C, Walker C, O'Shaughnessy D, Efthimiadis A, Hargreave FE, Sears MR : Differential cell counts in sputum in respiratory epidemiology: a pilot study. Chest 2001 ; 120 : 1107-13.
14. Covar RA, Szefler SJ, Martin RJ, Sundstrom DA, Silkoff PE, Murphy J, Young DA, Spahn JD : Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 2003 ; 142 : 469-75.
15. Rosias PP, Dompeling E, Dentener MA, Pennings HJ, Hendriks HJ, Van Iersel MP, Jobsis Q : Childhood asthma: exhaled markers of airway inflammation, asthma control score, and lung function tests. Pediatr Pulmonol 2004 ; 38 : 107-14.
16. Leuppi JD, Downs SH, Downie SR, Marks GB, Salome CM : Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms. Thorax 2002 ; 57 : 518-23.
17. Spergel JM, Fogg MI, Bokszczanin-Knosala A : Correlation of exhaled nitric oxide, spirometry and asthma symptoms. J Asthma 2005 ; 42 : 879-83.
18. Fitzpatrick AM, Gaston BM, Erzurum SC, Teague WG : Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide. J Allergy Clin Immunol 2006 ; 118 : 1218-25.
19. Artlich A, Busch T, Lewandowski K, Jonas S, Gortner L, Falke KJ : Childhood asthma: exhaled nitric oxide in relation to clinical symptoms. Eur Respir J 1999 ; 13 : 1396-401.
20. Mahut B, Delacourt C, Zerah-Lancner F, De Blic J, Harf A, Delclaux C : Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma. Chest 2004 ; 125 : 1012-8.
21. Franklin PJ, Turner SW, Le Souef PN, Stick SM : Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. Thorax 2003 ; 58 : 1048-52.
22. Fritsch M, Uxa S, Horak F, Jr., Putschoegl B, Dehlink E, Szepfalusi Z, Frischer T : Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol 2006 ; 41 : 855-62.
23. Paraskakis E, Brindicci C, Fleming L, Krol R, Kharitonov SA, Wilson NM, Barnes PJ, Bush A : Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma. Am J Respir Crit Care Med 2006 ; 174 : 260-7.
24. Delgado-Corcoran C, Kissoon N, Murphy SP, Duckworth LJ : Exhaled nitric oxide reflects asthma severity and asthma control. Pediatr Crit Care Med 2004 ; 5 : 48-52.
25. Brussee JE, Smit HA, Kerkhof M, Koopman LP, Wijga AH, Postma DS, Gerritsen J, Grobbee DE, Brunekreef B, de Jongste JC : Exhaled nitric oxide in 4-year-old children: relationship with asthma and atopy. Eur Respir J 2005 ; 25 : 455-61.
26. Strunk RC, Szefler SJ, Phillips BR, Zeiger RS, Chinchilli VM, Larsen G, Hodgdon K, Morgan W, Sorkness CA, Lemanske RF, Jr : Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 2003 ; 112 : 883-92.
27. Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, Khan M, Bush A : Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005 ; 171 : 1077-82.
28. Kharitonov SA, Donnelly LE, Montuschi P, Corradi M, Collins JV, Barnes PJ : Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 2002 ; 57 : 889-96.
29. Lehtimaki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E : Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J 2001 ; 18 : 635-9.
30. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR : Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005 ; 352 : 2163-73.
31. Sandrini A, Ferreira IM, Gutierrez C, Jardim JR, Zamel N, Chapman KR : Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest 2003 ; 124 : 1334-40.
32. Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A : Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001 ; 164 : 1376-81.
33. de Blic J, Tillie-Leblond I, Tonnel AB, Jaubert F, Scheinmann P, Gosset P : Difficult asthma in children: an analysis of airway inflammation. J Allergy Clin Immunol 2004 ; 113 : 94-100.
34. Ratnawati, Morton J, Henry RL, Thomas PS : Exhaled breath condensate nitrite/nitrate and pH in relation to pediatric asthma control and exhaled nitric oxide. Pediatr Pulmonol 2006 ; 41 : 929-36.
35. Brunetti L, Francavilla R, Tesse R, Strippoli A, Polimeno L, Loforese A, Miniello VL, Armenio L : Exhaled breath condensate pH measurement in children with asthma, allergic rhinitis and atopic dermatitis. Pediatr Allergy Immunol 2006 ; 17 : 422-7.
36. Lonnkvist K, Hellman C, Lundahl J, Hallden G, Hedlin G : Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal. J Allergy Clin Immunol 2001 ; 107 : 812-7.
37. Powell H, Gibson P : High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children (review). Cochrane Database Syst Rev 2003 ; 4 : CD004109.
38. Sin DD, Man SF : Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med 2002 ; 162 : 1591-5.
39. Suissa S, Ernst P : Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001 ; 107 : 937-44.
40. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B : Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000 ; 343 : 332-6.
41. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A : Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997 ; 337 : 1405-11.
42. Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O'Byrne PM, Lofdahl CG, Pauwels RA, Ullman A : Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999 ; 160 : 594-9.
43. Tillie-Leblond I, Godard P : Introduction pour le texte court de la conférence d'experts de la Société de Pneumologie de Langue Française (SPLF) sur Asthme et Allergie. Rev Mal Respir 2007 ; 24 : 221-2.
44. Murray CS, Poletti G, Kebadze T, Morris J, Woodcock A, Johnston SL, Custovic A : Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006 ; 61 : 376-82.
45. Johnston NW, Sears MR : Asthma exacerbations: Epidemiology. Thorax 2006 ; 61 : 722-8.
46. Subbarao P, Dorman SC, Rerecich T, Watson RM, Gauvreau GM, O'Byrne PM : Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy. J Allergy Clin Immunol 2005 ; 115 : 745-50.
47. Friedlander SL, Busse WW : The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol 2005 ; 116 : 267-73.
48. Hashimoto K, Ishii Y, Uchida Y, Kimura T, Masuyama K, Morishima Y, Hirano K, Nomura A, Sakamoto T, Takano H, Sagai M, Sekizawa K : Exposure to diesel exhaust exacerbates allergen-induced airway responses in guinea pigs. Am J Respir Crit Care Med 2001 ; 164 : 1957-63.
49. Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A : Differences between asthma exacerbations and poor asthma control. Lancet 1999 ; 353 : 364-9.
50. Grunberg K, Sharon RF, Sont JK, In 't Veen JC, Van Schadewijk WA, De Klerk EP, Dick CR, Van Krieken JH, Sterk PJ : Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med 2001 ; 164 : 1816-22.
51. Di Franco A, Bartoli ML, Carnevali S, Cianchetti S, Bacci E, Dente FL, Giannini D, Taccola M, Vagaggini B, Paggiaro PL : Analysis of sputum cell counts during spontaneous moderate exacerbations of asthma in comparison to the stable phase. J Asthma 2003 ; 40 : 155-62.
52. Fahy JV, Kim KW, Liu J, Boushey HA : Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995 ; 95 : 843-52.
53. Pizzichini MM, Pizzichini E, Clelland L, Efthimiadis A, Mahony J, Dolovich J, Hargreave FE : Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med 1997 ; 155 : 1501-8.
54. Rosi E, Lanini B, Ronchi MC, Romagnoli I, Stendardi L, Bianchi R, Zonefrati R, Duranti R, Scano G : Dyspnea, respiratory function and sputum profile in asthmatic patients during exacerbations. Respir Med 2002 ; 96 : 745-50.
55. Gibson PG, Woolley KL, Carty K, Murree-Allen K, Saltos N : Induced sputum eosinophil cationic protein (ECP) measurement in asthma and chronic obstructive airway disease (COAD). Clin Exp Allergy 1998 ; 28 : 1081-8.
56. in't Veen JC, Smits HH, Hiemstra PS, Zwinderman AE, Sterk PJ, Bel EH : Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med 1999 ; 160 : 93-9.
57. Salome CM, Leuppi JD, Freed R, Marks GB : Perception of airway narrowing during reduction of inhaled corticosteroids and asthma exacerbation. Thorax 2003 ; 58 : 1042-7.
58. Norzila MZ, Fakes K, Henry RL, Simpson J, Gibson PG : Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med 2000 ; 161 : 769-74.
59. Corne JM, Holgate ST : Mechanisms of virus induced exacerbations of asthma. Thorax 1997 ; 52 : 380-9.
60. Coyle AJ, Erard F, Bertrand C, Walti S, Pircher H, Le Gros G : Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia. J Exp Med 1995 ; 181 : 1229-33.
61. O'Sullivan S, Cormican L, Faul JL, Ichinohe S, Johnston SL, Burke CM, Poulter LW : Activated, cytotoxic CD8(+) T lymphocytes contribute to the pathology of asthma death. Am J Respir Crit Care Med 2001 ; 164 : 560-4.
62. Azzawi M, Johnston PW, Majumdar S, Kay AB, Jeffery PK : T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am Rev Respir Dis 1992 ; 145 : 1477-82.
63. Tillie-Leblond I, Hammad H, Desurmont S, Pugin J, Wallaert B, Tonnel AB, Gosset P : CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment. Am J Respir Crit Care Med 2000 ; 162 : 586-92.
64. Boniface S, Koscher V, Mamessier E, El Biaze M, Dupuy P, Lorec AM, Guillot C, Badier M, Bongrand P, Vervloet D, Magnan A : Assessment of T lymphocyte cytokine production in induced sputum from asthmatics: a flow cytometry study. Clin Exp Allergy 2003 ; 33 : 1238-43.
65. Jatakanon A, Lim S, Barnes PJ : Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000 ; 161 : 64-72.
66. Pizzichini MM, Pizzichini E, Clelland L, Efthimiadis A, Pavord I, Dolovich J, Hargreave FE : Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J 1999 ; 13 : 15-21.
67. Castro M, Bloch SR, Jenkerson MV, DeMartino S, Hamilos DL, Cochran RB, Zhang XE, Wang H, Bradley JP, Schechtman KB, Holtzman MJ : Asthma exacerbations after glucocorticoid withdrawal reflects T cell recruitment to the airway. Am J Respir Crit Care Med 2004 ; 169 : 842-9.
68. British Thoracic Society, Scottish intercollegiate Guidelines Network. British guidelines on the management of asthma. A national clinical guideline. Revised edition November 2005. http://www.enterpriseportal2.co.uk/filestore/bts/ asthmaupdatenov05.pdf.
69. Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemiere C, Pizzichini E, Cartier A, Hussack P, Goldsmith CH, Laviolette M, Parameswaran K, Hargreave FE : Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006 ; 27 : 483-94.
70. Pijnenburg MW, Hofhuis W, Hop WC, De Jongste JC : Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005 ; 60 : 215-8.
71. Lanz MJ, Leung DY, White CW : Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children. Ann Allergy Asthma Immunol 1999 ; 82 : 161-4.
72. Shaw DE, Berry MA, Thomas M, Green RH, Brightling CE, Wardlaw AJ, Pavord ID : The Use of Exhaled Nitric Oxide to Guide Asthma Management: A Randomised Controlled Trial. Am J Respir Crit Care Med 2007 ; Epub ahead of print.
73. Manning HL, Schwartzstein RM : Pathophysiology of Dyspnea. N Engl J Med 1995 ; 333 : 1547-53.
74. Banzett RB, Dempsey JA, O'Donnell DE, Wamboldt MZ : Symptom perception and respiratory sensation in asthma. Am J Respir Crit Care Med 2000 ; 162 : 1178-82.
75. Magadle R, Berar-Yanay N, Weiner P : The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea. Chest 2002 ; 121 : 329-33.
76. Fritz GK, Yeung A, Wamboldt MZ, Spirito A, McQuaid EL, Klein R, Seifer R : Conceptual and methodologic issues in quantifying perceptual accuracy in childhood asthma. J Pediatr Psychol 1996 ; 21 : 153-73.
77. Yoos HL, Kitzman H, McMullen A, Sidora K : Symptom perception in childhood asthma: how accurate are children and their parents? J Asthma 2003 ; 40 : 27-39.
78. Panditi S, Silverman M : Perception of exercise induced asthma by children and their parents. Arch Dis Child 2003 ; 88 : 807-11.
79. Killian KJ, Jones NL : Respiratory muscles and dyspnea. Clin Chest Med 1988 ; 9 : 237-48.
80. Fessler HE, Brower RG, Permutt S : CPAP reduces inspiratory work more than dyspnea during hyperinflation with intrinsic PEEP. Chest 1995 ; 108 : 432-40.
81. Lougheed MD, Lam M, Forkert L, Webb KA, O'Donnell DE : Breathlessness during acute bronchoconstriction in asthma. Pathophysiologic mechanisms. Am Rev Respir Dis 1993 ; 148 : 1452-9.
82. Yan S : Sensation of inspiratory difficulty during inspiratory threshold and hyperinflationary loadings. Effect of inspiratory muscle strength. Am J Respir Crit Care Med 1999 ; 160 : 1544-9.
83. Burdon JG, Juniper EF, Killian KJ, Hargreave FE, Campbell EJ : The perception of breathlessness in asthma. Am Rev Respir Dis 1982 ; 126 : 825-8.
84. Ottanelli R, Rosi E, Romagnoli I, Ronchi MC, Lanini B, Grazzini M, Filippelli M, Stendardi L, Duranti R, Scano G : Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma. Clin Sci (Lond) 2000 ; 98 : 681-7.
85. Rubinfeld AR, Pain MC : Conscious perception of bronchospasm as a protective phenomenon in asthma. Chest 1977 ; 72 : 154-8.
86. Hudgel DW, Cooperson DM, Kinsman RA : Recognition of added resistive loads in asthma: the importance of behavioral styles. Am Rev Respir Dis 1982 ; 126 : 121-5.
87. Peiffer C, Toumi M, Razzouk H, Marsac J, Lockhart A : Relationship between spontaneous dyspnoea and lability of airway obstruction in asthma. Clin Sci (Lond) 1992 ; 82 : 717-24.
88. Coleridge JC, Coleridge HM : Afferent vagal C fibre innervation of the lungs and airways and its functional significance. Rev Physiol Biochem Pharmacol 1984 ; 99 : 1-110.
89. Paintal AS : Vagal sensory receptors and their reflex effects. Physiol Rev 1973 ; 53 : 159-227.
90. Barnes PJ : Poorly perceived asthma. Thorax 1992 ; 47 : 408-9.
91. Kelsen SG, Prestel TF, Cherniack NS, Chester EH, Deal EC, Jr : Comparison of the respiratory responses to external resistive loading and bronchoconstriction. J Clin Invest 1981 ; 67 : 1761-8.
92. Moy ML, Woodrow Weiss J, Sparrow D, Israel E, Schwartzstein RM : Quality of dyspnea in bronchoconstriction differs from external resistive loads. Am J Respir Crit Care Med 2000 ; 162 : 451-5.
93. Taguchi O, Kikuchi Y, Hida W, Iwase N, Satoh M, Chonan T, Takishima T : Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea. J Appl Physiol 1991 ; 71 : 2183-90.
94. Lee LY, Morton RF : Pulmonary chemoreflex sensitivity is enhanced by prostaglandin E2 in anesthetized rats. J Appl Physiol 1995 ; 79 : 1679-86.
95. Holgate ST, Church MK, Polosa R : Adenosine: a positive modulator of airway inflammation in asthma. Ann N Y Acad Sci 1991 ; 629 : 227-36.
96. Ho CY, Gu Q, Hong JL, Lee LY : Prostaglandin E(2) enhances chemical and mechanical sensitivities of pulmonary C fibers in the rat. Am J Respir Crit Care Med 2000 ; 162 : 528-33.
97. Holtzman MJ, Zhang V, Hussain H, Roswit WT, Wilson JD : Prostaglandin H synthase and lipoxygenase gene families in the epithelial cell barrier. Ann N Y Acad Sci 1994 ; 744 : 58-77.
98. Preas HL, 2nd, Jubran A, Vandivier RW, Reda D, Godin PJ, Banks SM, Tobin MJ, Suffredini AF : Effect of endotoxin on ventilation and breath variability: role of cyclooxygenase pathway. Am J Respir Crit Care Med 2001 ; 164 : 620-6.
99. DeLa Cadena RA, Suffredini AF, Page JD, Pixley RA, Kaufman N, Parrillo JE, Colman RW : Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. Blood 1993 ; 81 : 3313-7.
100. Coleridge HM, Coleridge JC : Pulmonary reflexes: neural mechanisms of pulmonary defense. Annu Rev Physiol 1994 ; 56 : 69-91.
101. Kubin L, Alheid GF, Zuperku EJ, McCrimmon DR : Central pathways of pulmonary and lower airway vagal afferents. J Appl Physiol 2006 ; 101 : 618-27.
102. Joos GF, O'Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlen B, DiMaria G, Foresi A, Hargreave FE, Holgate ST, Inman M, Lotvall J, Magnussen H, Polosa R, Postma DS, Riedler J : Indirect airway challenges. Eur Respir J 2003 ; 21 : 1050-68.
103. Sont JK, Booms P, Bel EH, Vandenbroucke JP, Sterk PJ : The severity of breathlessness during challenges with inhaled methacholine and hypertonic saline in atopic asthmatic subjects. The relationship with deep breath-induced bronchodilation. Am J Respir Crit Care Med 1995 ; 152 : 38-44.
104. Pliss LB, Ingenito EP, Ingram RH, Jr : Responsiveness, inflammation, and effects of deep breaths on obstruction in mild asthma. J Appl Physiol 1989 ; 66 : 2298-304.
105. Pliss LB, Ingenito EP, Ingram RH, Jr., Pichurko B : Assessment of bronchoalveolar cell and mediator response to isocapnic hyperpnea in asthma. Am Rev Respir Dis 1990 ; 142 : 73-8.
106. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, et al : Eosinophilic inflammation in asthma. N Engl J Med 1990 ; 323 : 1033-9.
107. De Monchy JG, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, De Vries K : Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985 ; 131 : 373-6.
108. Bousquet J, Chanez P, Vignola AM, Lacoste JY, Michel FB : Eosinophil inflammation in asthma. Am J Respir Crit Care Med 1994 ; 150 : S33-8.
109. Roisman GL, Peiffer C, Lacronique JG, Le Cae A, Dusser DJ : Perception of bronchial obstruction in asthmatic patients. Relationship with bronchial eosinophilic inflammation and epithelial damage and effect of corticosteroid treatment. J Clin Invest 1995 ; 96 : 12-21.
110. in't Veen JC, Smits HH, Ravensberg AJ, Hiemstra PS, Sterk PJ, Bel EH : Impaired perception of dyspnea in patients with severe asthma. Relation to sputum eosinophils. Am J Respir Crit Care Med 1998 ; 158 : 1134-41.
111. Ottanelli R, Rosi E, Romagnoli I, Grazzini M, Stendardi L, Duranti R, Scano G : Do inhaled corticosteroids affect perception of dyspnea during bronchoconstriction in asthma? Chest 2001 ; 120 : 770-7.
112. Turcotte H, Corbeil F, Boulet LP : Perception of breathlessness during bronchoconstriction induced by antigen, exercise, and histamine challenges. Thorax 1990 ; 45 : 914-8.
113. Turcotte H, Boulet LP : Perception of breathlessness during early and late asthmatic responses. Am Rev Respir Dis 1993 ; 148 : 514-8.
114. Marks GB, Yates DH, Sist M, Ceyhan B, De Campos M, Scott DM, Barnes PJ : Respiratory sensation during bronchial challenge testing with methacholine, sodium metabisulphite, and adenosine monophosphate. Thorax 1996 ; 51 : 793-8.
115. Noseda A, De Bruyne I, De Maertelaer V, Yernault JC : Does an IV bolus of methylprednisolone relieve dyspnea in asthma exacerbations? Chest 2000 ; 118 : 1530-7.
116. Fahy JV, Boushey HA : Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation. Eur Respir J 1998 ; 11 : 1240-7.
117. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID : Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002 ; 57 : 875-9.
118. Massasso DH, Salome CM, King GG, Seale JP, Woolcock AJ : Do subjects with asthma have greater perception of acute bronchoconstriction than smokers with airflow limitation? Respirology 1999 ; 4 : 393-9.
119. Rutgers SR, ten Hacken NH, Koeter GH, Postma DS : Borg scores before and after challenge with adenosine 5′-monophosphate and methacholine in subjects with COPD and asthma. Eur Respir J 2000 ; 16 : 486-90.
120. Ottanelli R, Rosi E, Ronchi MC, Grazzini M, Lanini B, Stendardi L, Romagnoli I, Bertini S, Duranti R, Scano G : Perception of bronchoconstriction in smokers with airflow limitation. Clin Sci (Lond) 2001 ; 101 : 515-22.
121. Keatings VM, Barnes PJ : Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997 ; 155 : 449-53.
122. Ronchi MC, Piragino C, Rosi E, Amendola M, Duranti R, Scano G : Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax 1996 ; 51 : 1000-4.
123. Thompson AB, Rennard SI : Assessment of airways inflammation in chronic bronchitis. Eur Respir J 1993 ; 6 : 461-4.
124. Kleis S, Chanez P, Delvaux M, Louis R : Perception of dyspnea in mild smoking asthmatics. Respir Med 2007 ; 101 : 1426-30.
125. von Leupoldt A, Kanniess F, Dahme B : The influence of corticosteroids on the perception of dyspnea in asthma. Respir Med 2007 ; 101 : 1079-87.
126. Higgs CM, Laszlo G : Influence of treatment with beclomethasone, cromoglycate and theophylline on perception of bronchoconstriction in patients with bronchial asthma. Clin Sci (Lond) 1996 ; 90 : 227-34.
127. Boulet LP, Turcotte H, Cartier A, Milot J, Cote J, Malo JL, Laviolette M : Influence of beclomethasone and salmeterol on the perception of methacholine-induced bronchoconstriction. Chest 1998 ; 114 : 373-9.
128. Bijl-Hofland ID, Cloosterman SG, Folgering HT, van den Elshout FJ, van Weel C, van Schayck CP : Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma. Am J Respir Crit Care Med 2001 ; 164 : 764-9.
129. Salome CM, Reddel HK, Ware SI, Roberts AM, Jenkins CR, Marks GB, Woolcock AJ : Effect of budesonide on the perception of induced airway narrowing in subjects with asthma. Am J Respir Crit Care Med 2002 ; 165 : 15-21.
130. Manser R, Reid D, Abramson M : Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev 2001 : CD001740.
131. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW : Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2000 : CD002178.
132. Rodrigo G, Rodrigo C : Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med 1998 ; 157 : 698-703.
133. Rowe BH, Bota GW, Fabris L, Therrien SA, Milner RA, Jacono J : Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA 1999 ; 281 : 2119-26.
134. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE : Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004 ; 170 : 836-44.
135. Juniper EF, Kline PA, Vanzieleghem MA, Hargreave FE : Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 1991 ; 87 : 483-9.
136. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB : Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004 ; 113 : 59-65.
137. Boulet LP, Boulet V, Milot J : How should we quantify asthma control? A proposal. Chest 2002 ; 122 : 2217-23.
138. LeBlanc A, Robichaud P, Lacasse Y, Boulet LP : Quantification of asthma control: validation of the Asthma Control Scoring System. Allergy 2007 ; 62 : 120-5.
139. Kuna P, Peters MJ, Manjra AI, Jorup C, Naya IP, Martinez-Jimenez NE, Buhl R : Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract 2007 ; 61 : 725-36.
140. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG : Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006 ; 368 : 744-53.